174 related articles for article (PubMed ID: 31519200)
1. Relationship between plasma Atherogenic index and final pathology of Bosniak III-IV renal masses: a retrospective, single-center study.
Karabay E; Karsiyakali N; Duvar S; Tosun C; Aslan AR; Yucebas OE
BMC Urol; 2019 Sep; 19(1):85. PubMed ID: 31519200
[TBL] [Abstract][Full Text] [Related]
2. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and predictors of benign lesions in renal masses smaller than 7 cm presumed to be renal cell carcinoma.
Akdogan B; Gudeloglu A; Inci K; Gunay LM; Koni A; Ozen H
Clin Genitourin Cancer; 2012 Jun; 10(2):121-5. PubMed ID: 22401753
[TBL] [Abstract][Full Text] [Related]
4. Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery.
Janssen MWW; Linxweiler J; Philipps I; Bütow Z; Siemer S; Stöckle M; Ohlmann CH
World J Surg Oncol; 2018 Feb; 16(1):35. PubMed ID: 29463251
[TBL] [Abstract][Full Text] [Related]
5. Long-term oncological outcomes of cystic renal cell carcinoma according to the Bosniak classification.
Boissier R; Ouzaid I; Nouhaud FX; Khene Z; Dariane C; Chkir S; Chelly S; Giwerc A; Allenet C; Lefrancq JB; Gimel P; Bodin T; Rioux-Leclercq N; Correas JM; Albiges L; Hetet JF; Bigot P; Bernhard JC; Long JA; Mejean A; Bensalah K;
Int Urol Nephrol; 2019 Jun; 51(6):951-958. PubMed ID: 30977021
[TBL] [Abstract][Full Text] [Related]
6. Partial Nephrectomy for Presumed Renal-Cell Carcinoma: Incidence, Predictors, and Perioperative Outcomes of Benign Lesions.
Bauman TM; Potretzke AM; Wright AJ; Knight BA; Vetter JM; Figenshau RS
J Endourol; 2017 Apr; 31(4):412-417. PubMed ID: 28068796
[TBL] [Abstract][Full Text] [Related]
7. Is it possible to predict the complexity of peripheral artery disease with atherogenic index?
Mesut E; Cihan A; Orhan G
Vascular; 2020 Oct; 28(5):513-519. PubMed ID: 32390562
[TBL] [Abstract][Full Text] [Related]
8. Sex, age, and surgeon decision on nephron-sparing surgery are independent predictors of renal masses with benign histologic findings--a multicenter survey.
Zisman A; Patard JJ; Raz O; Klatte T; Haifler M; Mendlovic S; Sandbank J; Belldegrun AS; Lindner A; Leibovici D; Pantuck AJ
Urology; 2010 Sep; 76(3):541-6. PubMed ID: 20494411
[TBL] [Abstract][Full Text] [Related]
9. Development of a clinical prediction model for assessment of malignancy risk in Bosniak III renal lesions.
Goenka AH; Remer EM; Smith AD; Obuchowski NA; Klink J; Campbell SC
Urology; 2013 Sep; 82(3):630-5. PubMed ID: 23876583
[TBL] [Abstract][Full Text] [Related]
10. Development and prospective validation of a novel weighted quantitative scoring system aimed at predicting the pathological features of cystic renal masses.
Li Y; Dai C; Bian T; Zhou J; Xiang Z; He M; Huang J; Zhu Y; Hu X; Jiang S; Guo J; Wang H
Eur Radiol; 2019 Apr; 29(4):1809-1819. PubMed ID: 30311030
[TBL] [Abstract][Full Text] [Related]
11. [The gender features of disorders of composition of lipids of blood serum in patients with chronic pathology of kidneys.].
Murkamilov IT; Aytabaiev KA; Fomin VV; Murkamilova ZA; Rayimjanov ZR; Redjapova NA; Yusupov FA; Aydarov ZA
Klin Lab Diagn; 2018; 63(3):152-158. PubMed ID: 30673194
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of Additional Clinical and Radiological Parameters for Discrimination of Malignancy in Bosniak 3 Cysts.
Sefik E; Bozkurt IH; Oguzdogan GY; Çelik S; Basmaci I; Gorgel SN; Aydin E; Adibelli ZH; Vardar E; Gunlusoy B; Degirmenci T
Urol Int; 2021; 105(1-2):118-123. PubMed ID: 33242872
[TBL] [Abstract][Full Text] [Related]
13. Can a Modified Bosniak Classification System Risk Stratify Pediatric Cystic Renal Masses?
Saltzman AF; Carrasco A; Colvin AN; Meyers ML; Cost NG
J Urol; 2018 Aug; 200(2):434-439. PubMed ID: 29572157
[TBL] [Abstract][Full Text] [Related]
14. Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis.
Ball MW; Gorin MA; Bhayani SB; Rogers CG; Stifelman MD; Kaouk JH; Zargar H; Marshall S; Larson JA; Rahbar HM; Trock BJ; Pierorazio PM; Allaf ME
Urol Oncol; 2015 Mar; 33(3):112.e9-14. PubMed ID: 25499258
[TBL] [Abstract][Full Text] [Related]
15. Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies.
Tsui KH; Shvarts O; Barbaric Z; Figlin R; de Kernion JB; Belldegrun A
J Urol; 2000 Feb; 163(2):437-41. PubMed ID: 10647649
[TBL] [Abstract][Full Text] [Related]
16. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery.
Butler BP; Novick AC; Miller DP; Campbell SA; Licht MR
Urology; 1995 Jan; 45(1):34-40; discussion 40-1. PubMed ID: 7817478
[TBL] [Abstract][Full Text] [Related]
17. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
18. Pre-treatment neutrophil-to-lymphocyte ratio predicts tumor pathology in newly diagnosed renal tumors.
Viers BR; Thompson RH; Lohse CM; Cheville JC; Leibovich BC; Boorjian SA; Tollefson MK
World J Urol; 2016 Dec; 34(12):1693-1699. PubMed ID: 27052014
[TBL] [Abstract][Full Text] [Related]
19. Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: prevalence and predictors in Korean patients.
Jeon HG; Lee SR; Kim KH; Oh YT; Cho NH; Rha KH; Yang SC; Han WK
Urology; 2010 Sep; 76(3):574-9. PubMed ID: 20303148
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of anatomic and morphologic nomogram to predict malignant and high-grade disease in a cohort of patients with small renal masses.
Bagrodia A; Harrow B; Liu ZW; Olweny EO; Faddegon S; Yin G; Tan YK; Han WK; Lotan Y; Margulis V; Cadeddu JA
Urol Oncol; 2014 Jan; 32(1):37.e17-23. PubMed ID: 23628308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
